Importantly, we were able to validate both known TDP-43 interactors reported in InWeb (validation rate of 10/11, or 90.9%; including all five of the tested ALS-relevant proteins) and newly identified interactors (validation rate of 11/12, or 91.7%) with the same degree of success. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.